Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat

Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat

A 45-year man with a chronic hepatitis B virus (HBV) infection, elevated alphafetoprotein (AFP) 628ng/dL and Abdominal CT-scan features of Hepatocellular Carcinoma was admitted with polycythemia condition (haemoglobin 20.4g/dL, haematocrit 65.4%). Elevated of erythropoietin (EPO) serum level confirm...

Full description

Bibliographic Details
Main Authors:	Poernomo Budi Setiawan, Ummi Maimunah, Nenci Siagian
Format:	Article
Language:	English
Published:	Interna Publishing 2020-07-01
Series:	The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Subjects:	hepatocellular carcinoma (hcc) polycythemial trans arterial chemotherapy and embolization (tace)
Online Access:	https://www.ina-jghe.com/index.php/jghe/article/view/733

Similar Items

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang JH, et al.
Published: (2015-09-01)

Trans-Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single Tertiary Care Institute Experience
by: Parvez Ahmed, et al.
Published: (2023-07-01)

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
by: Jing-Xuan Xu, et al.
Published: (2023-12-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

EFFICACY OF INTRA-ARTERIAL LIDOCAINE FOR PAIN CONTROL RESULTING FROM TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
by: Ghulam Abbas, et al.
Published: (2021-06-01)

Transarterial Chemoebolization in Hepatocellular Carcinoma: A Binational Japanese-German Study
by: Auer TA, et al.
Published: (2022-08-01)

Evaluation of patients undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with respect to tumor size, site and number of lesions
by: Amjad Sattar, et al.
Published: (2013-12-01)

Combination of intrahepatic TARE and extrahepatic TACE to treat HCC patients with extrahepatic artery supply: A case series
by: Lorenzo Carlo Pescatori, et al.
Published: (2024-03-01)

Transradial approach for transarterial chemoembolization of hepatocellular carcinoma in Egyptian patients: Initial study
by: Mohamed El-Gharib, et al.
Published: (2016-09-01)

Effect of prophylactic transcatheter arterial chemoembolization on hepatocellular carcinoma with microvascular invasion after R0 resection. A case-control study
by: Ke-Yue Li, et al.
Published: (2020-04-01)

Mortality Evaluation and Life Expectancy Prediction of Patients with Hepatocellular Carcinoma with Data Mining
by: Che-Yu Liu, et al.
Published: (2023-03-01)

Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma
by: Seiichi Mawatari, et al.
Published: (2022-12-01)

Common interventional techniques (single versus combined) in management of hepatocellular carcinoma
by: Mostafa M. Shakweer, et al.
Published: (2016-12-01)

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
by: V. V. Breder, et al.
Published: (2018-07-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
by: Chang WC, et al.
Published: (2021-08-01)

Can triphasic hepatic multislice CT validate the LI-RADS treatment response algorithm after trans-catheter arterial chemoembolization treatment of hepatocellular carcinoma?
by: Hany El-Assaly, et al.
Published: (2023-01-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization
by: ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti
Published: (2022-05-01)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
by: Christine Koch, et al.
Published: (2021-04-01)

Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report
by: Fulvio Gasparrini, M.D., et al.
Published: (2021-09-01)

Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-08-01)

A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study
by: Zong‐Han Liu, et al.
Published: (2023-05-01)

Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation
by: Kai Lei, et al.
Published: (2023-08-01)

Intermediate stage hepatocellular carcinoma: a summary review
by: Elshaarawy O, et al.
Published: (2019-07-01)

The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions
by: Adam McCulloch, et al.
Published: (2018-06-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Guiding Value of Circulating Tumor Cells for Preoperative Transcatheter Arterial Embolization in Solitary Large Hepatocellular Carcinoma: A Single-Center Retrospective Clinical Study
by: Qiao Zhang, et al.
Published: (2022-05-01)

CT perfusion in hepatocellular carcinoma: Is it reliable?
by: Mennatallah Hatem Shalaby, et al.
Published: (2017-12-01)

Heamodynamic Doppler changes in portal pressure after trans-arterial chemoembolization of hepatocellular carcinoma.
by: Yasmine Ali, et al.
Published: (2022-01-01)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
by: Chengjian He, et al.
Published: (2022-06-01)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
by: Rong Cai, et al.
Published: (2017-11-01)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
by: Andrew M. Brown, et al.
Published: (2023-02-01)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01)

Role of PET CT in comparison to triphasic CT in early follow-up of hepatocellular carcinoma after transarterial chemoemoblization
by: Waleed M. Hetta, et al.
Published: (2020-02-01)

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE
by: Wang H, et al.
Published: (2022-02-01)

Advances in the treatment of hepatocellular carcinoma using drug-eluting beads
by: Guangxu Wei, et al.
Published: (2020-09-01)

The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
by: María Pipa-Muñiz, et al.
Published: (2020-06-01)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
by: Maria Tampaki, et al.
Published: (2020-01-01)

Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Jun-Ning Liu, et al.
Published: (2023-02-01)